Citation Impact
Citing Papers
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Evaluation of Antibacterial Activities of Some Medicinal Plants, Traditionally Used in Iran
2012
Nosocomial Infections Due to Multidrug‐Resistant Pseudomonas aeruginosa: Epidemiology and Treatment Options
2005
Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria
2015
G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children – safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847]
2004
Metal nanoparticles: understanding the mechanisms behind antibacterial activity
2017 Standout
Sepsis biomarkers: a review
2010 Standout
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
2013 Standout
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia
2005
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Chemical composition and inhibitory parameters of essential oil and extracts of Nandina domestica Thunb. to control food-borne pathogenic and spoilage bacteria
2008
Procalcitonin Test in the Diagnosis of Bacteremia: A Meta-analysis
2006
Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin
1998
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
2008
Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia
2004
Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies
2006
The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
2000 Standout
Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
2005
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Vancomycin resistance: occurrence, mechanisms and strategies to combat it
2003
Procalcitonine et méningites virales : réduction des traitements antibiotiques inutiles par le dosage en routine au cours d’une épidémie
2002
Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa
2005
Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome*
2008
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening
2013
Essential oils from aromatic herbs as antimicrobial agents
2011 Standout
Chemical composition, antibacterial and antioxidant activities of leaf essential oil and extracts of Metasequioa glyptostroboides Miki ex Hu
2009
The Clinical Value of Procalcitonin and Neopterin in Predicting Sepsis and Organ Failure After Major Trauma
2003
Pseudomonas Skin Infection
2011
Vertebral Osteomyelitis
2010 Standout
Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis
2007
Levofloxacin
1998
Multidrug resistance to antimicrobials as a predominant factor influencing patient survival
2006
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
New antimicrobial agents as therapy for resistant gram-positive cocci
2007
Serum miR-146a and miR-223 as potential new biomarkers for sepsis
2010
Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock
2003
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Pseudomonas aeruginosa Disrupts Caenorhabditis elegans Iron Homeostasis, Causing a Hypoxic Response and Death
2013 StandoutNobel
Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis
2006
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections
2008
The antimicrobial activity of nanoparticles: present situation and prospects for the future
2017 Standout
Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis
2008 Standout
Fever of Unknown Origin in Febrile Leukopenia
2007
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Antibacterial activity and mechanism of cinnamon essential oil against Escherichia coli and Staphylococcus aureus
2015 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Antimicrobial herb and spice compounds in food
2010 Standout
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein
2004
Procalcitonin: A Marker of Bacteraemia in SIRS
2003
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
The efficacy of the antibacterial peptide, pyrrhocoricin, is finely regulated by its amino acid residues and active domains
2001
Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii
2001
Toward Resolving the Challenges of Sepsis Diagnosis
2004
Production of polyunsaturated single cell oils possessing antimicrobial and anticancer properties
2015
The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa
2006
Procalcitonin as a Diagnostic Aid in Diabetic Foot Infections
2007
Walking the fine line between intracellular and membrane activities of antibacterial peptides
2003 StandoutNobel
Point-of-Care Diagnostics for Global Health
2008 Standout
Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials
2020 Standout
Bacterial Adhesion: Seen Any Good Biofilms Lately?
2002 Standout
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
The efficacy of the antibacterial peptide, pyrrhocoricin, is finely regulated by its amino acid residues and active domains
2001
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
Prosthetic Joint Infection
2014 Standout
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
2013
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of P. Grecka being referenced
In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates
1998
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation
1998
Sitafloxacin (DU-6859a) and trovafloxacin: postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus
1999
Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa
1997
Assessment of Procalcitonin as a Diagnostic Marker of Underlying Infection in Patients with Febrile Neutropenia
2001
In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa
1996
Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?
2004
Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study
2004
Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?
2002
Impact of n-6 Polyunsaturated Fatty Acids on Growth of Multidrug-Resistant Pseudomonas aeruginosa : Interactions with Amikacin and Ceftazidime
2000
Comparative In Vitro Activity and Killing Effect of Trovafloxacin, DU-6859a, Levofloxacin and Sparfloxacin against Staphylococcus aureus
1997
In vitro interactions of γ‐Linolenic acid and arachidonic acid with ceftazidime on multiresistantPseudomonas aeruginosa
1999
In-vitro activity of FK 037 (Cefoselis), a novel 4th generation Cephalosporin, compared to Cefepime and Cefpirome on nosocomial staphylococci and gram-negative isolates☆
2000